Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes.
作者信息
Rayman G, Lumb A N, Kennon B, Cottrell C, Nagi D, Page E, Voigt D, Courtney H C, Atkins H, Higgins K, Platts J, Dhatariya K, Patel M, Newland-Jones P, Narendran P, Kar P, Burr O, Thomas S, Stewart R
机构信息
The Ipswich Diabetes Centre, East Suffolk and North Essex NHS Foundation Trust, Colchester.
Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford.
出版信息
Diabet Med. 2021 Jan;38(1):e14378. doi: 10.1111/dme.14378. Epub 2020 Sep 21.
Abstract
摘要
相似文献
1
Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes.COVID-19患者的地塞米松治疗：对糖尿病患者和非糖尿病患者血糖管理的影响及指导
Diabet Med. 2021 Jan;38(1):e14378. doi: 10.1111/dme.14378. Epub 2020 Sep 21.
2
Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story.羟氯喹、COVID-19 和糖尿病。为什么这是一个不同的故事。
Diabetes Metab Res Rev. 2021 Feb;37(2):e3379. doi: 10.1002/dmrr.3379. Epub 2020 Jul 20.
3
COVID-19 and dexamethasone-induced hyperglycaemia: Workload implications for diabetes inpatient teams.新型冠状病毒肺炎与地塞米松诱发的高血糖症：对糖尿病住院团队工作量的影响
Diabet Med. 2022 Feb;39(2):e14716. doi: 10.1111/dme.14716. Epub 2021 Oct 22.
4
COVID-19 and diabetes mellitus. Importance of glycemic control.2019冠状病毒病与糖尿病。血糖控制的重要性。
Clin Investig Arterioscler. 2021 May-Jun;33(3):148-150. doi: 10.1016/j.arteri.2021.05.001.
5
Effect of COVID 19 pneumonia on hyperglycemia: Is it different from non COVID pneumonia?新型冠状病毒肺炎对高血糖的影响：与非新型冠状病毒肺炎是否不同？
Diabetes Metab Syndr. 2022 Feb;16(2):102407. doi: 10.1016/j.dsx.2022.102407. Epub 2022 Jan 19.
6
Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.COVID-19 时代糖尿病患者的心血管风险管理问题。
Diabetes Care. 2020 Jul;43(7):1427-1432. doi: 10.2337/dc20-0941. Epub 2020 May 14.
7
An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting.COVID-19 与糖尿病患者：住院环境中的病理生理学与注意事项概述。
Diabet Med. 2021 Mar;38(3):e14509. doi: 10.1111/dme.14509. Epub 2021 Feb 5.
8
One year into the clash of pandemics of diabetes and COVID-19: Lessons learnt and future perspectives.在糖尿病和 COVID-19 大流行冲突的一年中：经验教训和未来展望。
J Diabetes Investig. 2022 Jan;13(1):19-21. doi: 10.1111/jdi.13644. Epub 2021 Sep 1.
9
Use of Continuous Glucose Monitor in Critically Ill COVID-19 Patients Requiring Insulin Infusion: An Observational Study.使用连续血糖监测仪在需要胰岛素输注的危重症 COVID-19 患者中的应用：一项观察性研究。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4007-e4016. doi: 10.1210/clinem/dgab409.
10
Does glycemic control affect outcome of COVID-19?血糖控制是否会影响新型冠状病毒肺炎的预后？
J Diabetes. 2020 Dec;12(12):868-869. doi: 10.1111/1753-0407.13116. Epub 2020 Oct 3.
引用本文的文献
1
COVID-19 management in patients with comorbid conditions.合并症患者的 COVID-19 管理。
World J Virol. 2025 Jun 25;14(2):102674. doi: 10.5501/wjv.v14.i2.102674.
2
Impact of diabetes on COVID-19 and glucocorticoids on patients with COVID-19 and diabetes during the Omicron variant epidemic: a multicenter retrospective cohort study in South China.奥密克戎变异株流行期间糖尿病对 COVID-19 的影响及糖皮质激素对 COVID-19 合并糖尿病患者的影响：华南地区多中心回顾性队列研究。
BMC Infect Dis. 2024 Jul 18;24(1):706. doi: 10.1186/s12879-024-09287-z.
3
Continuous glucose monitoring profile in COVID-19 patients with and without diabetes receiving methylprednisolone.接受甲泼尼龙治疗的合并或未合并糖尿病的COVID-19患者的连续血糖监测情况
Endocrine. 2024 Nov;86(2):556-563. doi: 10.1007/s12020-024-03841-0. Epub 2024 May 31.
4
Role of renin-angiotensin system/angiotensin converting enzyme-2 mechanism and enhanced COVID-19 susceptibility in type 2 diabetes mellitus.肾素-血管紧张素系统/血管紧张素转换酶2机制在2型糖尿病中增强新型冠状病毒肺炎易感性的作用
World J Diabetes. 2024 Apr 15;15(4):606-622. doi: 10.4239/wjd.v15.i4.606.
5
Tipped Over the Edge: A Case of Diabetes Ketoacidosis Precipitated by High-Dose Steroids in the Setting of a Large Peritonsillar Abscess.病情恶化：一例因大剂量类固醇诱发糖尿病酮症酸中毒合并巨大扁桃体周脓肿的病例
Cureus. 2024 Mar 25;16(3):e56917. doi: 10.7759/cureus.56917. eCollection 2024 Mar.
6
Glucocorticoid-Induced Hyperglycemia: A Neglected Problem.糖皮质激素诱导性高血糖：一个被忽视的问题。
Endocrinol Metab (Seoul). 2024 Apr;39(2):222-238. doi: 10.3803/EnM.2024.1951. Epub 2024 Mar 27.
7
Optimal initial insulin dosage for managing steroid-induced hyperglycemia in hospitalized COVID-19 patients: A retrospective single-center study.住院COVID-19患者中管理类固醇诱导的高血糖的最佳初始胰岛素剂量：一项回顾性单中心研究。
SAGE Open Med. 2024 Mar 20;12:20503121241238148. doi: 10.1177/20503121241238148. eCollection 2024.
8
[Current Status of Research on COVID-19 Patients With Concomitant Hyperglycemia and the Management Strategies of Hyperglycemia].[新型冠状病毒肺炎合并高血糖患者的研究现状及高血糖管理策略]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Jan 20;55(1):230-235. doi: 10.12182/20240160602.
9
Diabetes Mellitus, Energy Metabolism, and COVID-19.糖尿病、能量代谢与 COVID-19
Endocr Rev. 2024 Mar 4;45(2):281-308. doi: 10.1210/endrev/bnad032.
10
Metabolomic Profile, Plasmatic Levels of Losartan and EXP3174, Blood Pressure Control in Hypertensive Patients and Their Correlation with COVID-19.代谢组学特征、氯沙坦及EXP3174的血浆水平、高血压患者的血压控制及其与COVID-19的相关性
Pharmaceuticals (Basel). 2023 Sep 13;16(9):1290. doi: 10.3390/ph16091290.
本文引用的文献
1
New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic.2019冠状病毒病大流行期间住院患者高血糖管理新指南
Diabet Med. 2020 Jul;37(7):1210-1213. doi: 10.1111/dme.14327. Epub 2020 Jun 8.
2
Practical recommendations for the management of diabetes in patients with COVID-19.关于 COVID-19 患者糖尿病管理的实用建议。
Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550. doi: 10.1016/S2213-8587(20)30152-2. Epub 2020 Apr 23.
3
Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group.高血糖和类固醇（糖皮质激素）治疗的管理：联合英国糖尿病学会（JBDS）住院治疗组的指南。
Diabet Med. 2018 Aug;35(8):1011-1017. doi: 10.1111/dme.13675.
4
Maintaining glycaemic control during high-dose prednisolone administration for hyperemesis gravidarum in Type 1 diabetes.1型糖尿病合并妊娠剧吐患者在大剂量泼尼松龙治疗期间维持血糖控制。
Diabet Med. 2004 Mar;21(3):298-9. doi: 10.1046/j.1464-5491.2003.01026_21_3.x-i1.
Zotero 插件